Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
01 1CENTRIENT PHARMACEUTICALS NETHERLANDS B.V. Delft NL
02 2DR. REDDY'S LABORATORIES LIMITED Hyderabad IN
03 4TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL
04 1AMOLI ORGANICS PRIVATE LIMITED Mumbai IN
05 1APITORIA PHARMA PRIVATE LIMITED Hyderabad IN
06 1ARCH PHARMALABS LIMITED Mumbai IN
07 1AUROBINDO PHARMA LIMITED Hyderabad IN
08 1BIOCON LIMITED Bengaluru IN
09 1CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram IN
10 1Changzhou Pharmaceutical Factory Changzhou CN
11 1HEC PHARM GMBH Berlin DE
12 1HETERO LABS LIMITED Hyderabad IN
13 3KRKA, d.d., Novo mesto Novo mesto SI
14 1LAURUS LABS LIMITED Hyderabad IN
15 1LUPIN LIMITED Mumbai IN
16 1MANKIND PHARMA LIMITED New Delhi IN
17 1MOREPEN LABORATORIES LIMITED Baddi IN
18 1MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor Village IN
19 1MSN PHARMACHEM PRIVATE LIMITED Sangareddy District IN
20 1NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo CN
21 1NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo Hi-Tech District CN
22 1SANECA PHARMACEUTICALS A.S. Hlohovec SK
23 1SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN
24 2SYNTHIMED LABS PRIVATE LIMITED Derabassi IN
25 1TIANISH LABORATORIES PRIVATE LIMITED Hyderabad IN
26 1ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD. Xiangtan Village CN
27 1ZHEJIANG HONGYUAN PHARMACEUTICAL CO., LTD. Taizhou CN
28 1ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City CN
29 2ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD. Taizhou City CN
30 2ZHEJIANG LEPU PHARMACEUTICAL CO., LTD Taizhou City CN
31 1ZYDUS LIFESCIENCES LIMITED Ankleshwar IN
32 3ZYDUS LIFESCIENCES LIMITED Vadodara IN
33 1Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN
01 20Atorvastatin calcium
02 1Atorvastatin calcium, 315313
03 1Atorvastatin calcium, 317500
04 1Atorvastatin calcium, AS
05 1Atorvastatin calcium, Crystalline
06 1Atorvastatin calcium, Form I, ATN process
07 2Atorvastatin calcium, Form-I
08 1Atorvastatin calcium, IM2 process
09 1Atorvastatin calcium, JA
10 1Atorvastatin calcium, Micronised
11 1Atorvastatin calcium, Process 2
12 1Atorvastatin calcium, Process 4, polymorphic form-I
13 1Atorvastatin calcium, Process I
14 3Atorvastatin calcium, Process II
15 1Atorvastatin calcium, Process-III
16 1Atorvastatin calcium, Process-IV
17 1Atorvastatin calcium, Process-VIII
18 1Atorvastatin calcium, Site 2
19 1Atorvastatin calcium, TBAH Sulphate Route
20 2Atorvastatin calcium, Trihydrate
21 1Atorvastatin calcium, Trihydrate, Form-1
01 12China
02 1Gabon
03 22India
04 4Israel
05 1Netherlands
06 1Slovakia
07 3Slovenia
01 1Expired
02 38Valid
03 5Withdrawn by Holder
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.
Certificate Number : CEP 2010-366 - Rev 07
Status : Valid
Issue Date : 2024-12-10
Type : Chemical
Substance Number : 2191
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Certificate Number : CEP 2011-222 - Rev 02
Status : Valid
Issue Date : 2023-09-11
Type : Chemical
Substance Number : 2191
Certificate Number : R1-CEP 2018-059 - Rev 00
Status : Valid
Issue Date : 2023-06-30
Type : Chemical
Substance Number : 2191
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Atorvastatin Calcium, Form I, ATN Process
Certificate Number : R0-CEP 2020-092 - Rev 02
Status : Valid
Issue Date : 2023-06-02
Type : Chemical
Substance Number : 2191
Certificate Number : R1-CEP 2012-035 - Rev 02
Status : Valid
Issue Date : 2022-08-22
Type : Chemical
Substance Number : 2191
Certificate Number : CEP 2022-099 - Rev 01
Status : Valid
Issue Date : 2024-03-15
Type : Chemical
Substance Number : 2191
Certificate Number : R1-CEP 2013-024 - Rev 01
Status : Valid
Issue Date : 2020-05-28
Type : Chemical
Substance Number : 2191
Atorvastatin Calcium, Process-VIII
Certificate Number : CEP 2013-094 - Rev 04
Status : Valid
Issue Date : 2024-04-16
Type : Chemical
Substance Number : 2191
Certificate Number : CEP 2011-184 - Rev 04
Status : Valid
Issue Date : 2024-09-27
Type : Chemical
Substance Number : 2191
Atorvastatin Calcium, Process-III
Certificate Number : R0-CEP 2020-309 - Rev 01
Status : Valid
Issue Date : 2022-07-26
Type : Chemical
Substance Number : 2191
A Atorvastatin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atorvastatin, including repackagers and relabelers. The FDA regulates Atorvastatin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atorvastatin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atorvastatin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atorvastatin supplier is an individual or a company that provides Atorvastatin active pharmaceutical ingredient (API) or Atorvastatin finished formulations upon request. The Atorvastatin suppliers may include Atorvastatin API manufacturers, exporters, distributors and traders.
click here to find a list of Atorvastatin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Atorvastatin CEP of the European Pharmacopoeia monograph is often referred to as a Atorvastatin Certificate of Suitability (COS). The purpose of a Atorvastatin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Atorvastatin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Atorvastatin to their clients by showing that a Atorvastatin CEP has been issued for it. The manufacturer submits a Atorvastatin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Atorvastatin CEP holder for the record. Additionally, the data presented in the Atorvastatin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Atorvastatin DMF.
A Atorvastatin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Atorvastatin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Atorvastatin suppliers with CEP (COS) on PharmaCompass.
We have 29 companies offering Atorvastatin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?